Posted in


Researchers present inner workings of Ebola vaccine trial

An experimental vaccine combined with an innovative way of vaccinating people has resulted in an estimated 100 percent efficacy of the vaccine against the Ebola virus in West Africa — and the approach could establish a new way of responding to outbreaks of emerging pathogens, including the Zika virus.

Ira Longini and WHO team lead breakthrough Ebola vaccine trial

The world’s largest outbreak of the Ebola virus has infected more than 28,000 people and killed more than 11,000 since March 2014 when the epidemic began spreading across West Africa. In July 2015 the World Health Organization announced a major development in the Ebola fight:

PhD Student Interns with Bayer Healthcare

Qi An, a third year PhD student in Biostatistics, has accepted a 12-week clinical statistics summer internship with Bayer HealthCare in Whippany, New Jersey.  As an intern within the Clinical Statistics US Department, she will gain a direct view into research and development at Bayer and witness how clinical…

Paper Points to Most Effective Vaccine Trials for Epidemics, including Ebola

Implementing a vaccine trial during an epidemic can be difficult, particularly in countries with poor transportation, limited vaccine supplies and difficulty predicting how widespread a disease may become — conditions such as those in West Africa during the recent Ebola outbreak. Now, a University of Florida Health researcher with…